- call +1-201-465-4211
- email sales@mrinsights.biz
Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations.
Scope of the Report:
This report studies the Genome Editing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Genome Editing market by product type and applications/end industries.
The increasing application of genome engineering in treating chronic ailments and therapeutics will be one of the key factors fueling the growth of genome editing market during the next few years. With the continuous prevalence of infectious and chronic diseases such as hepatitis, tuberculosis, malaria, HIV/AIDS, and others, the application of genome editing in treating these ailments has increased considerably in the recent years. According to CDC, there were about 1.8 million new cases of HIV reported in 2016. Such a rapidly increasing number of HIV cases have led to the researchers to work on new gene-based therapies for reducing morbidity and mortality of HIV-infected patients. Consequently, the rise in prevalence of such ailments will impact the demand for novel therapies equipping several genome editing tools in the forthcoming years.
The North American region is expected to hold the largest share of the global market in 2017. This regional segment is also expected to grow at the highest CAGR during the forecast period. The large share and high growth rate of this region can be attributed to factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding.
The global Genome Editing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Genome Editing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Genscript
Horizon Discovery Group
Lonza
Merck KGaA
Sangamo Therapeutics
Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
CRISPR
TALEN
ZFN
Market Segment by Applications, can be divided into
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Genome Editing Market Overview
1.1 Product Overview and Scope of Genome Editing
1.2 Classification of Genome Editing by Types
1.2.1 Global Genome Editing Revenue Comparison by Types (2017-2023)
1.2.2 Global Genome Editing Revenue Market Share by Types in 2017
1.2.3 CRISPR
1.2.4 TALEN
1.2.5 ZFN
1.3 Global Genome Editing Market by Application
1.3.1 Global Genome Editing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cell Line Engineering
1.3.3 Animal Genetic Engineering
1.3.4 Plant Genetic Engineering
1.4 Global Genome Editing Market by Regions
1.4.1 Global Genome Editing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Genome Editing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Genome Editing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genome Editing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Genome Editing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genome Editing Status and Prospect (2013-2023)
1.5 Global Market Size of Genome Editing (2013-2023)
2 Manufacturers Profiles
2.1 Genscript
2.1.1 Business Overview
2.1.2 Genome Editing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Genscript Genome Editing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Horizon Discovery Group
2.2.1 Business Overview
2.2.2 Genome Editing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Horizon Discovery Group Genome Editing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Lonza
2.3.1 Business Overview
2.3.2 Genome Editing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Lonza Genome Editing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck KGaA
2.4.1 Business Overview
2.4.2 Genome Editing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck KGaA Genome Editing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sangamo Therapeutics
2.5.1 Business Overview
2.5.2 Genome Editing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sangamo Therapeutics Genome Editing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Thermo Fisher Scientific
2.6.1 Business Overview
2.6.2 Genome Editing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Thermo Fisher Scientific Genome Editing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Genome Editing Market Competition, by Players
3.1 Global Genome Editing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Genome Editing Players Market Share
3.2.2 Top 10 Genome Editing Players Market Share
3.3 Market Competition Trend
4 Global Genome Editing Market Size by Regions
4.1 Global Genome Editing Revenue and Market Share by Regions
4.2 North America Genome Editing Revenue and Growth Rate (2013-2018)
4.3 Europe Genome Editing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Genome Editing Revenue and Growth Rate (2013-2018)
4.5 South America Genome Editing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Genome Editing Revenue and Growth Rate (2013-2018)
5 North America Genome Editing Revenue by Countries
5.1 North America Genome Editing Revenue by Countries (2013-2018)
5.2 USA Genome Editing Revenue and Growth Rate (2013-2018)
5.3 Canada Genome Editing Revenue and Growth Rate (2013-2018)
5.4 Mexico Genome Editing Revenue and Growth Rate (2013-2018)
6 Europe Genome Editing Revenue by Countries
6.1 Europe Genome Editing Revenue by Countries (2013-2018)
6.2 Germany Genome Editing Revenue and Growth Rate (2013-2018)
6.3 UK Genome Editing Revenue and Growth Rate (2013-2018)
6.4 France Genome Editing Revenue and Growth Rate (2013-2018)
6.5 Russia Genome Editing Revenue and Growth Rate (2013-2018)
6.6 Italy Genome Editing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Genome Editing Revenue by Countries
7.1 Asia-Pacific Genome Editing Revenue by Countries (2013-2018)
7.2 China Genome Editing Revenue and Growth Rate (2013-2018)
7.3 Japan Genome Editing Revenue and Growth Rate (2013-2018)
7.4 Korea Genome Editing Revenue and Growth Rate (2013-2018)
7.5 India Genome Editing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Genome Editing Revenue and Growth Rate (2013-2018)
8 South America Genome Editing Revenue by Countries
8.1 South America Genome Editing Revenue by Countries (2013-2018)
8.2 Brazil Genome Editing Revenue and Growth Rate (2013-2018)
8.3 Argentina Genome Editing Revenue and Growth Rate (2013-2018)
8.4 Colombia Genome Editing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Genome Editing by Countries
9.1 Middle East and Africa Genome Editing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Genome Editing Revenue and Growth Rate (2013-2018)
9.3 UAE Genome Editing Revenue and Growth Rate (2013-2018)
9.4 Egypt Genome Editing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Genome Editing Revenue and Growth Rate (2013-2018)
9.6 South Africa Genome Editing Revenue and Growth Rate (2013-2018)
10 Global Genome Editing Market Segment by Type
10.1 Global Genome Editing Revenue and Market Share by Type (2013-2018)
10.2 Global Genome Editing Market Forecast by Type (2018-2023)
10.3 CRISPR Revenue Growth Rate (2013-2023)
10.4 TALEN Revenue Growth Rate (2013-2023)
10.5 ZFN Revenue Growth Rate (2013-2023)
11 Global Genome Editing Market Segment by Application
11.1 Global Genome Editing Revenue Market Share by Application (2013-2018)
11.2 Genome Editing Market Forecast by Application (2018-2023)
11.3 Cell Line Engineering Revenue Growth (2013-2018)
11.4 Animal Genetic Engineering Revenue Growth (2013-2018)
11.5 Plant Genetic Engineering Revenue Growth (2013-2018)
12 Global Genome Editing Market Size Forecast (2018-2023)
12.1 Global Genome Editing Market Size Forecast (2018-2023)
12.2 Global Genome Editing Market Forecast by Regions (2018-2023)
12.3 North America Genome Editing Revenue Market Forecast (2018-2023)
12.4 Europe Genome Editing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Genome Editing Revenue Market Forecast (2018-2023)
12.6 South America Genome Editing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Genome Editing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Genome Editing Picture
Table Product Specifications of Genome Editing
Table Global Genome Editing and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
